Single-use filtration assemblies are disposable systems that are used to filter and purify biopharmaceutical products, such as vaccines, monoclonal antibodies, cell therapies, and gene therapies. They consist of various components, such as filters, tubing, connectors, bags, and sensors, that are pre-assembled and sterilized for one-time use. Single-use filtration assemblies offer several advantages over conventional stainless steel systems, such as reduced risk of contamination, lower capital and operating costs, faster turnaround time, and greater flexibility and scalability.
The single-use filtration assemblies market size value in 2023 was USD 5.40 billion and is anticipated to grow at a CAGR of 17.4% during the forecast period of 2024-2032 driven by the increasing adoption of single-use technologies in biopharmaceutical manufacturing across the globe. The global single-use filtration assemblies market share is anticipated to achieve a value of USD 22.88 billion by 2032. In this blog post, we will explore the various factors that are influencing the growth of this market, the challenges and opportunities that it faces, the segmentation and analysis of the market by product type, application, end-user, and region, the recent developments and innovations in the market, the competitive landscape and the key players, and the frequently asked questions (FAQs) about the market.
Single-Use Filtration Assemblies Market Dynamics
The single-use filtration assemblies market is driven by several factors, such as:
- The increasing demand for biopharmaceutical products, especially in the wake of the COVID-19 pandemic, which has boosted the need for rapid and efficient production of vaccines and therapeutics.
- The growing adoption of single-use technologies in biopharmaceutical manufacturing, as they offer greater flexibility, scalability, and efficiency, as well as lower environmental impact and regulatory compliance.
- The rising focus on quality and safety of biopharmaceutical products, which requires high levels of sterility and purity, and reduces the risk of cross-contamination and human error.
- The technological advancements and innovations in the field of single-use filtration assemblies, such as the development of novel filter materials, membranes, and sensors, that enhance the performance and functionality of the systems.
However, the single-use filtration assemblies market also faces some challenges, such as:
- The high initial cost of single-use filtration assemblies, which may deter some small and medium-sized biopharmaceutical manufacturers from adopting them.
- The limited availability and supply of single-use filtration assemblies, especially in emerging markets, where the demand for biopharmaceutical products is growing rapidly.
- The regulatory and environmental concerns regarding the disposal and recycling of single-use filtration assemblies, which may pose a threat to the sustainability and social responsibility of the market.
External Single-Use Filtration Assemblies Market Trends
Some of the external trends that are influencing the single-use filtration assemblies market are:
- The increasing outsourcing of biopharmaceutical manufacturing to contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs), which are more likely to adopt single-use technologies to cater to the diverse and changing needs of their clients.
- The emergence of new biopharmaceutical modalities, such as cell and gene therapies, which require more complex and customized filtration and purification processes, and can benefit from the flexibility and scalability of single-use filtration assemblies.
- The growing awareness and adoption of Industry 4.0 and digitalization in biopharmaceutical manufacturing, which enables the integration of single-use filtration assemblies with smart sensors, data analytics, and automation, to enhance the process control, quality, and efficiency of the systems.
Single-Use Filtration Assemblies Market Segmentation
The single-use filtration assemblies market can be segmented by product type, application, end-user, and region.
- By product type, the market can be divided into cartridge filters, capsule filters, membrane filters, syringe filters, and others. The cartridge filters segment accounted for the largest share of the market in 2023, due to their wide range of applications, high flow rates, and ease of use. The membrane filters segment is expected to witness the highest growth rate during the forecast period, due to their high efficiency, selectivity, and compatibility with various biopharmaceutical products.
- By application, the market can be categorized into upstream processing, downstream processing, and fill-finish operations. The downstream processing segment dominated the market in 2023, as it involves the critical steps of purification and separation of biopharmaceutical products, which require high-quality and reliable filtration systems. The upstream processing segment is projected to grow at the fastest rate during the forecast period, as it involves the cultivation and harvesting of biopharmaceutical products, which require sterile and robust filtration systems.
- By end-user, the market can be classified into biopharmaceutical companies, CMOs and CDMOs, research and academic institutes, and others. The biopharmaceutical companies segment held the largest share of the market in 2023, as they are the major consumers of single-use filtration assemblies for their in-house production of biopharmaceutical products. The CMOs and CDMOs segment is anticipated to grow at the highest CAGR during the forecast period, as they are the major adopters of single-use technologies for their outsourced production of biopharmaceutical products.
- By region, the market can be segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. North America accounted for the largest share of the market in 2023, due to the presence of a large number of biopharmaceutical companies, CMOs and CDMOs, research and academic institutes, and leading single-use filtration assemblies manufacturers in the region. Asia-Pacific is expected to register the highest growth rate during the forecast period, due to the increasing demand for biopharmaceutical products, the rising investments in biopharmaceutical manufacturing, and the growing adoption of single-use technologies in the region.
Single-Use Filtration Assemblies Market Growth
The single-use filtration assemblies market is expected to grow at a CAGR of 17.4% during the forecast period of 2024-2032, reaching a value of USD 22.88 billion by 2032. The market growth is driven by the increasing demand for biopharmaceutical products, the growing adoption of single-use technologies in biopharmaceutical manufacturing, the rising focus on quality and safety of biopharmaceutical products, and the technological advancements and innovations in the field of single-use filtration assemblies. The market growth is also supported by the external trends, such as the increasing outsourcing of biopharmaceutical manufacturing, the emergence of new biopharmaceutical modalities, and the growing awareness and adoption of Industry 4.0 and digitalization in biopharmaceutical manufacturing. The market growth is, however, hampered by some challenges, such as the high initial cost of single-use filtration assemblies, the limited availability and supply of single-use filtration assemblies, and the regulatory and environmental concerns regarding the disposal and recycling of single-use filtration assemblies.
Recent Developments in the Single-Use Filtration Assemblies Market
Some of the recent developments and innovations in the single-use filtration assemblies market are:
- In March 2021, Pall Corporation, a leading provider of single-use filtration assemblies, launched the Cadence BioSMB Process system, a single-use, continuous multicolumn chromatography system, that offers improved productivity, flexibility, and scalability for biopharmaceutical purification processes.
- In February 2021, Sartorius Stedim Biotech, a leading provider of single-use filtration assemblies, introduced the Sartocheck 5 Plus filter integrity tester, a device that combines speed, accuracy, and ease of use for testing the integrity of single-use filters and filter systems.
- In January 2021, Merck KGaA, a leading provider of single-use filtration assemblies, announced the expansion of its Mobius single-use manufacturing facility in Danvers, Massachusetts, USA, to meet the growing demand for single-use technologies and solutions for biopharmaceutical manufacturing.
Single-Use Filtration Assemblies Market Analysis
The single-use filtration assemblies market is a highly competitive and fragmented market, with the presence of several global and regional players. The key players in the market include Pall Corporation, Sartorius Stedim Biotech, Merck KGaA, Thermo Fisher Scientific, GE Healthcare, Parker Hannifin, Repligen Corporation, 3M, EMD Millipore, and Meissner Filtration Products. These players are adopting various strategies, such as product launches, expansions, acquisitions, partnerships, and collaborations, to enhance their market position and gain a competitive edge in the market. The market analysis also includes the patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, and partnerships and collaborations analysis by the leading key players.
Key Players in the Single-Use Filtration Assemblies Market
Some of the key players in the single-use filtration assemblies market are:
- Pall Corporation: Pall Corporation is a global leader in filtration, separation, and purification solutions for the biopharmaceutical, food and beverage, industrial, and aerospace industries. The company offers a wide range of single-use filtration assemblies, such as Allegro single-use systems, Kleenpak single-use systems, Cadence single-use systems, and Mustang single-use systems, for various biopharmaceutical applications, such as cell culture, harvest, clarification, chromatography, virus filtration, and sterile filtration. The company operates in more than 70 countries and has over 10,000 employees.
- Sartorius Stedim Biotech: Sartorius Stedim Biotech is a leading provider of single-use technologies and solutions for biopharmaceutical manufacturing. The company offers a comprehensive portfolio of single-use filtration assemblies, such as Sartoflow single-use systems, Sartopore single-use systems, Sartoclear single-use systems, and Sartoguard single-use systems, for various biopharmaceutical applications, such as cell culture, harvest, clarification, chromatography, virus filtration, and sterile filtration. The company operates in more than 110 countries and has over 7,000 employees.
- Merck KGaA: Merck KGaA is a global science and technology company that operates in three business sectors: healthcare, life science, and performance materials. The company offers a broad range of single-use filtration assemblies, such as Mobius single-use systems, Millipore Express single-use systems, Millistak single-use systems, and Pellicon single-use systems, for various biopharmaceutical applications, such as cell culture, harvest, clarification, chromatography, virus filtration, and sterile filtration. The company operates in more than 60 countries and has over 57,000 employees.
Media Contact:
Company Name: Claight Corporation
Contact Person: Joe Goldberg, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA